• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Mid-America Apartment Communities

Mid-America Apartment Communities

Mid-America Apartment Communities Inc MAA

Last Price$96.18Day Change (%)0.31%
Open Price$95.55Day Change ($)0.30
Day Range94.28–96.8252-Week Range78.72–110.01

As of Fri 9/23/2016 6:01:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. U.S. FDA Approves Labeling Update of REXULTI® (brexpiprazole) For Maintenance Treatment of Schizophrenia

    U.S. FDA Approves Labeling Update of REXULTI® (brexpiprazole) For Maintenance Treatment of Schizophrenia

  2. Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe

    Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe

  3. Exelixis Announces Outcome from First Planned Interim Analysis of the Phase 3 CELESTIAL Trial of Cabozantinib in Patients with Advanced Hepatocellular Carcinoma

    Exelixis Announces Outcome from First Planned Interim Analysis of the Phase 3 CELESTIAL Trial of Cabozantinib in Patients with Advanced Hepatocellular Carcinoma

  4. Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment

    Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment

  5. Kiadis Pharma announces Financial Results for the six months ended June 30, 2016

    Kiadis Pharma announces Financial Results for the six months ended June 30, 2016

  6. Profit from the Housing Crash

    The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.